Vectibix: payments to doctors
Payments that named Vectibix as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.3M
- Providers
- 5,311
- Transactions
- 13,549
- Average per transaction
- $93
The per-transaction average — $93 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 5,311 providers the average total is $238, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Amgen | $1,265,774 | 100.0% |